Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Bone Marrow Transplantation|February 16, 2000
Dose-intense paclitaxel, etoposide and cyclophosphamide: a safe and active regimen for tumor cytoreduction and stem cell mobilization in metastatic breast cancerS Bilgrami, J M Feingold, R D Bona, et al.
The Journal of Reproductive Medicine|December 1, 1985
Positive correlation between mature amniotic fluid optical density readings and the absence of neonatal hyaline membrane diseaseC L Cetrulo, A J Sbarra, R J Selvaraj, et al.
JAMA|March 6, 1991
The effect of standard- and high-dose epinephrine on coronary perfusion pressure during prolonged cardiopulmonary resuscitationN A Paradis, G B Martin, J Rosenberg, et al.
Acta Haematologica|January 13, 2001
Kaposi's sarcoma following allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemiaB C de Medeiros, W N Rezuke, A Ricci, et al.
Bone Marrow Transplantation|April 1, 1999
Varicella zoster virus infection associated with high-dose chemotherapy and autologous stem-cell rescueS Bilgrami, N G Chakraborty, F Rodriguez-Pinero, et al.
The Annals of Pharmacotherapy|February 24, 2001
Idiopathic pneumonia syndrome following myeloablative chemotherapy and autologous transplantationS F Bilgrami, M L Metersky, D McNally, et al.
American Journal of Human Genetics|March 1, 1996
FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicingG A Meyers, D Day, R Goldberg, et al.
American Journal of Human Genetics|June 19, 1998
Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutationsW A Paznekas, M L Cunningham, T D Howard, et al.
The Johns Hopkins Medical Journal|October 1, 1975
Mucolipidosis III (pseudo-Hurler polydystrophy): Clinical and laboratory studies in a series of 12 patientsT E Kelly, G H Thomas, H A Taylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2019
A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin LymphomaBrad S Kahl, Mehdi Hamadani, John Radford, et al.
Pageof 12